Banyan Security, Keyfactor, ObserveID, Simeio and strongDM also join alliance to develop identity-centric security strategies…
BOCA RATON, Florida., Feb. 08, 2022 (GLOBE NEWSWIRE) — INmune Bio, Inc. (NASDAQ: INMB) (the “Company”),…
WORCESTER, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) — Mustang Bio, Inc. (“Mustang”) (NASDAQ: MBIO), a…
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) — Satsuma Pharmaceuticals, Inc. (Nasdaq: STSA),…
Joel Prieve brings nearly 20 years of commercial operations expertise and proven track record in…
INT301 Met Safety Goals Across Four Dose Levels in Cohort 1 Patient Treatment Now Ongoing…
Oslo, Norway, 8 February 2022 Vistin Pharma ASA will release its fourth quarter 2021 results…
No additional clinical work required; NDA resubmission anticipated in Q3 2022 NEW YORK, Feb. 08,…
– Ovid to License Gaboxadol to Healx – – Healx to Explore Gaboxadol in Combination…
BELTSVILLE, Md., Feb. 08, 2022 (GLOBE NEWSWIRE) — NextCure, Inc. (Nasdaq: NXTC), a clinical-stage biopharmaceutical…
GARDEN CITY, N.Y., Feb. 08, 2022 (GLOBE NEWSWIRE) — Beyond Air, Inc. (NASDAQ: XAIR), a…
REDWOOD CITY, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) — Soleno Therapeutics, Inc. (“Soleno”) (NASDAQ: SLNO),…
HOUSTON, Feb. 08, 2022 (GLOBE NEWSWIRE) — Salarius Pharmaceuticals, Inc. (Nasdaq: SLRX), a clinical-stage biopharmaceutical…
Incidence and Severity of Post-Surgical Intraabdominal Adhesions following Bowel Resection Surgery and Treatment with Enteral…
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) — Frontier Medicines Corporation, a precision…
GelStat Corporation Has Been Qualified by the SEC for a Regulation A+ Public Offering STUART,…
SOUTH SAN FRANCISCO, Calif., Feb. 08, 2022 (GLOBE NEWSWIRE) — Akero Therapeutics, Inc. (Nasdaq: AKRO), a clinical-stage…
CAMBRIDGE, Mass., Feb. 08, 2022 (GLOBE NEWSWIRE) — Werewolf Therapeutics, Inc. (the “Company” or “Werewolf”)…
Completed enrollment ahead of schedule in second Phase 3 FDA registration trial for Nyxol in…
Highlights: Seven subjects in cohort three intravenously dosed; RECCE® 327 at 500mg indicating to be…